Effects of Jianpi Jiedu Recipeon reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer

Chinese Journal of Integrative Medicine

Volumn 20, Issue 8, 2014, Pages 610-617

  Sui, Hua ^a   Zhu, Hui Rong ^a   Wu, Jie ^b   Nikitin, Alexander Yu ^c   Cai, Jian Feng ^d   Fan, Zhong Ze ^a   Li, Qi ^a  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c Department of Biomedical Sciences Cornell University ^*  (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Chinese medicine; colorectal cancer; cyclooxygenase 2; Jianpi Jiedu Recipe; multidrug resistance; multidrug resistance gene; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL; JIANPI JIEDU RECIPE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OXALIPLATIN; PIRARUBICIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VINBLASTINE; GREEN FLUORESCENT PROTEIN; HERBACEOUS AGENT; JIANPI JIEDU; PLATINUM COMPLEX; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MTT ASSAY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; GENETICS; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR SPACE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; P-GLYCOPROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VINBLASTINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905451181     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1452-4     Document Type: Article

References (26)

1. Ahmed FE. Molecular markers that predict response to colon cancer therapy. Expert Rev Mol Diagn 2005;5:353-375. (Pubitemid 40686096)
2. Sutoh I, Kohno H, Nakashima Y, Hishikawa Y, Tabara H, Tachibana M, et al. Concurent expressions of matallothionein, glutathione S-tansferase-, and P-glycoprotein in colorectal cancers. Dis Colon Rectum 2000,43:221-232. (Pubitemid 30115104)
3. Lazaris AC, Kavantzas NG, Zorzos HS, Tsavaris NV, Davaris PS. Markers of drug resistance in relapsing colon cancer. J Cancer Res Clin Oncol 2002;128:114-118.
4. Kang CD, Ahn BK, Jeong CS, Kim KW, Lee HJ, Yoo SD, et al. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein experimental. Cell Res 2000;256:300-307.
5. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH. Absence of pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999;104:1441-1447.
6. Kalle AM, Rizvi A. Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother 2011;55:439-442.
7. Chang CY, Huang ZN, Yu HH, Chang LH, Li SL, Chen YP. The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. J Ethnopharmacol 2008;118:387-395.
8. Li Q, Sui H, Liu X, Qin JM, Yin Ph, Fan ZZ. Reversal effect of Jianpi Jiedu Recioe on JNK/SAPK signal transduction pathway-mediated multidrug resistance in human colon carcinoma cells. Chin J Tradit Med Pharm (Chin) 2012;27:731-735.
9. Sui H, Jin BH, Yin PH, Fan ZZ, LI Q. Reversal effect of Jianpi Jiedu Recioe on multidrug resistance in human colon carcinoma cells. Chin J Exp Tradit Med Formul (Chin) 2012;18:181-185.
10. Xiu, SY. The experimental method of pharmacology. Beijing: The People's Public Health Publisher;1986:985-924.
11. Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G, et al. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS One 2011;6:e14648.
12. Sui H, Zhou SF, Wang Y, Liu X, Zhou LH, Yin PH, et al. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis 2011;32:667-675.
13. Morrison JG, White P, McDougall S, Firth JW, Woolfrey SG, Graham MA, et al. Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin. J Pharm Biomed Anal 2000;24:1-10.
14. Sui H, Fan ZZ, Li Q. Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells. J Int Med Res, 2012;40:426-435.
15. Sui H, Zhou LH, Yin PH, Wang Y, Fan ZZ, Zhou SF, et al. JNK signal transduction pathway regulates MDR1/P-glycoprotein-mediated multidrug resistance in colon carcinoma cells. World Chin J Digestol (Chin) 2011;19:892-898.
16. Sui H, Zhou LH, Liu X, Yin PH, Zhou N, Wang Y, et al. COX-2 egulate MDR1//P-glycoprotein-mediated multidrug resistance in colon carcinoma cells. Chin Oncol (Chin) 2011;21:241-246.
17. Xia W, Zhao T, Lv J, Xu S, Shi J, Wang S, et al. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner. J Cell Biochem 2009;108:181-194.
18. Pan QC, Tian H. Reversal of multidrug resistance by various principles from Chinese herbal medicine. Chin Sci Bull 1995;40:1901-1905.
19. Engi H, Hohmann J, Gang G, Pusztai R, Rédei D, Kovács O, et al. Chemoprevention and inhibition of pglycoprotein in cancer cells by Chinese medicinal herbs. Phytother Res 2008;22:1671-1676.
20. Ye Y, Chou GX, Mu DD, Wang H, Chu JH, Leung AK, et al. Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells. J Ethnopharmacol 2010;129:387-390.
21. Duan P, Wang ZM. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Chin J Integr Med 2002;22:515-517.
22. Sui H, Li Q. Clinical research of traditional Chinese medicine on treatment of colorectal cancer. Liaoning J Tradit Chin Med (Chin) 2009;36:1241-1243.
23. Sui H, Li Q. Mechanism research of JNK/SAPK signal transduction pathway and multidrug resistance. Cancer Res prev treatment (Chin) 2010;37:844-847.
24. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;343:1-19.
25. Liao B, Ge RY, Chen X, Huangfu ZP, Qi Y, Song YP, et al. Synergistic reversal effect of Chinese medicine compound FFJZ combined with cyclosporine A on multidrug resistance of leukemia K562/VCR cell line. J Exp Hematol (Chin) 2007;15:752-755.
26. Xutian S, Zhang J, Louise W. New exploration and understanding of traditional Chinese medicine. Am J Chin Med 2009;37:411-426.